CD80 and squamous cell carcinoma: Metastatic initiating cells can also co-opt CTLA-4 immune checkpoint to avoid T cell activation—for instance, TGF-β-induced CSC expression of CD80, leading to T cell inhibition through the CD80-CTLA-4 axis in pre-clinical models of squamous cell carcinoma [189].